Healthcare M&A Activity in Q3 Stabilizes
Despite all the headwinds straining the healthcare M&A market, deal activity stabilized in the third quarter of 2024, according to preliminary results in the LevinPro HC database. With 489 deals on the books in the last week of September, we saw only a marginal decline in activity compared with the second quarter of 2024 and year-over-year numbers. From April to June, there were 499 deals, and in Q3:23, activity reached 516 deals. Disclosed spending followed a similar trend to quarterly deal volumes, which is not always the case. Announced prices hit approximately $44 billion in Q3:24, a 7% decline compared to the second quarter ($47.4 billion) but a 7% year-over-year increase... Read More »
Most Active States for Healthcare Services M&A in 2024 (So Far)
As the healthcare industry continues to evolve, mergers and acquisitions (M&As) have become a strategic tool for providers to expand their reach, enhance services and improve efficiency. This year, certain states have emerged as particularly active hubs for healthcare services M&A. The healthcare services sectors included in this report include Behavioral Health Care, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Physician Medical Groups, Rehabilitation and Other Services (a mix of companies providing ancillary healthcare services, or those relating to healthcare). This analysis examines the most active U.S. states and regions... Read More »
Earnings Week in Review: Healthcare Giants Navigate Growth and Hurdles
We’re taking a look at some of the major companies reporting earnings in the week of July 15-July 19, across a variety of sectors. UnitedHealth Group and Novartis showcased strong growth, while Johnson & Johnson and Elevance Health presented more mixed results. Abbott Laboratories also reported solid results, driven by its medical devices segment, while facing challenges in its diagnostics business due to waning COVID-19 testing demand. This week’s earnings reports offer insights into the broader healthcare industry’s performance and future trajectory. UnitedHealth Group UnitedHealth Group (UHG) demonstrated a significant turnaround in its second quarter of 2024, posting a... Read More »
Private Equity M&A Activity in Healthcare Rises in Q2:24
Private equity (PE) investment has continued to play a substantial role in the healthcare M&A market. In the second quarter of 2024, there were 186 deals completed by PE companies or their sponsored companies (PE buyers, collectively), or approximately 38% of all the 496 announced healthcare deals, according to new data captured in the LevinPro HC database. This is a 24% increase from the first quarter of 2024 when 150 acquisitions from PE buyers were announced. Activity in Q2:24 represents a 17% decrease from Q2:23 when 224 PE buyer transactions were reported. In Q2:24, 10 transactions with a PE buyer had a disclosed price. The ten deals totaled more than $5.49 billion in announced... Read More »
Healthcare M&A Volume Drops in Q2:24, According to Acquisition Data from LevinPro HC
Healthcare merger and acquisition activity slightly decreased in the second quarter of 2024, with 496 deals announced, according to new acquisition data from LevinPro HC. Activity in the Q2:24 was 2% lower than in the first quarter, when 506 transactions were announced. However, it is a drop of 18% compared with activity in the second quarter of 2023, when 604 deals were announced. Activity in sectors such as Physician Medical Groups and Other Services drove much of the volume, with 124 and 135 deals, respectively. Demand for healthcare real estate, such as medical outpatient buildings and properties, has driven high deal volume in the Other Services for the past several years. Activity in... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
